How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Usutu Virus Antibody Dynamics in Naturally Infected Blackbirds, the Netherlands, 2016–2018 – Volume 31, Number 6—June 2025 – Emerging Infectious Diseases journal

Early Release – Oral Flea Preventive to Control Rickettsia typhi–Infected Fleas on Reservoir Opossums, Galveston, Texas, USA, 2023–2024 – Volume 31, Number 6—June 2025 – Emerging Infectious Diseases journal

Early Release – Prospective Multicenter Surveillance of Non–H. pylori Helicobacter Infections during Medical Checkups, Japan, 2022 – Volume 31, Number 6—June 2025 – Emerging Infectious Diseases journal

Early Release – Beyond the Brushstrokes—Illuminating Patterns and Interactions to Find Order in Complex Systems – Volume 31, Supplement—May 2025 – Emerging Infectious Diseases journal

Communicable disease threats report, 3 May – 9 May 2025, week 19

Early Release – 16S Ribosomal RNA Gene PCR and Sequencing for Pediatric Infection Diagnosis, United States, 2020–2023 – Volume 31, Supplement—May 2025 – Emerging Infectious Diseases journal

Early Release – Characterization of Adult and Pediatric Healthcare-Associated and Community-Associated Clostridioides difficile Infections, Canada, 2015–2022 – Volume 31, Number 6—June 2025 – Emerging Infectious Diseases journal

Early Release – Lessons from 5 Years of Routine Whole-Genome Sequencing for Epidemiologic Surveillance of Shiga Toxin–Producing Escherichia coli, France, 2018–2022 – Volume 31, Supplement—May 2025 – Emerging Infectious Diseases journal

Early Release – Nosocomial Transmission of Plasmodium falciparum Malaria, Spain, 2024 – Volume 31, Number 6—June 2025 – Emerging Infectious Diseases journal

Early Release – Effects of Decentralized Sequencing on National Listeria monocytogenes Genomic Surveillance, Australia, 2016–2023 – Volume 31, Supplement—May 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us